Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular

Emanuel Correia1, Bruno Rodrigues, Luís Ferreira Santos

  • 1Hospital S. Teotónio, Viseu, Portugal. emanuelbaptista@gmail.com

Insights

Reduced myocardial strain in hypertrophic cardiomyopathy (HCM) patients predicts nonsustained ventricular tachycardia (NSVT). This 2D speckle tracking measure aids in sudden cardiac death (SCD) risk stratification.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiac Electrophysiology

Background:

  • Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) remains challenging due to limitations of current risk factors.
  • Myocardial deformation analysis using 2D speckle tracking offers a novel approach to assess regional left ventricular (LV) function and its correlation with myocardial disarray and fibrosis.

Purpose of the Study:

  • To investigate the relationship between myocardial strain parameters derived from 2D speckle tracking and the occurrence of nonsustained ventricular tachycardia (NSVT) in patients with HCM.
  • To evaluate the potential of strain analysis as a new tool for SCD risk stratification in HCM.

Main Methods:

  • Thirty-two consecutive patients diagnosed with HCM underwent standard echocardiography and 2D speckle tracking strain analysis.
  • Twenty-four-hour Holter monitoring was performed to detect NSVT, and echocardiographic parameters were correlated with its presence.

Main Results:

  • Nine patients (28%) experienced NSVT. These patients exhibited higher maximal LV thickness compared to those without NSVT.
  • Significant reductions in mid septal, apical septal, apical lateral strain, and mean longitudinal strain were observed in patients with NSVT.
  • Midseptal strain < -10.5% demonstrated high sensitivity (89%) and specificity (74%) for predicting NSVT, independent of age or maximum wall thickness.

Conclusions:

  • Lower end-systolic peak longitudinal strain, as measured by 2D speckle tracking, is a significant predictor of NSVT in HCM patients.
  • This strain parameter holds promise as a valuable tool for improving SCD risk stratification in the HCM population.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...